These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 9374689)
21. Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistance, hyperinsulinemia, and increased adiposity. Araújo EP; De Souza CT; Gasparetti AL; Ueno M; Boschero AC; Saad MJ; Velloso LA Endocrinology; 2005 Mar; 146(3):1428-37. PubMed ID: 15550510 [TBL] [Abstract][Full Text] [Related]
22. Diversification of cardiac insulin signaling involves the p85 alpha/beta subunits of phosphatidylinositol 3-kinase. Kessler A; Uphues I; Ouwens DM; Till M; Eckel J Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E65-74. PubMed ID: 11120660 [TBL] [Abstract][Full Text] [Related]
23. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. Goodyear LJ; Giorgino F; Sherman LA; Carey J; Smith RJ; Dohm GL J Clin Invest; 1995 May; 95(5):2195-204. PubMed ID: 7537758 [TBL] [Abstract][Full Text] [Related]
24. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3' kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance. Vollenweider P; Ménard B; Nicod P Diabetes; 2002 Apr; 51(4):1052-9. PubMed ID: 11916925 [TBL] [Abstract][Full Text] [Related]
25. Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent. Ernsberger P; Koletsky RJ; Collins LA; Bedol D Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():275-82. PubMed ID: 8827950 [TBL] [Abstract][Full Text] [Related]
26. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Björnholm M; Kawano Y; Lehtihet M; Zierath JR Diabetes; 1997 Mar; 46(3):524-7. PubMed ID: 9032113 [TBL] [Abstract][Full Text] [Related]
28. Insulin signalling pathways in aorta and muscle from two animal models of insulin resistance--the obese middle-aged and the spontaneously hypertensive rats. Zecchin HG; Bezerra RM; Carvalheira JB; Carvalho-Filho MA; Metze K; Franchini KG; Saad MJ Diabetologia; 2003 Apr; 46(4):479-91. PubMed ID: 12679867 [TBL] [Abstract][Full Text] [Related]
29. Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance. Dal Ponte DB; Fogt DL; Jacob S; Henriksen EJ Metabolism; 1998 Aug; 47(8):982-7. PubMed ID: 9711996 [TBL] [Abstract][Full Text] [Related]
30. Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. Ikezu T; Okamoto T; Yonezawa K; Tompkins RG; Martyn JA J Biol Chem; 1997 Oct; 272(40):25289-95. PubMed ID: 9312146 [TBL] [Abstract][Full Text] [Related]
31. Enhanced insulin action on glucose transport and insulin signaling in 7-day unweighted rat soleus muscle. O'Keefe MP; Perez FR; Sloniger JA; Tischler ME; Henriksen EJ J Appl Physiol (1985); 2004 Jul; 97(1):63-71. PubMed ID: 15004002 [TBL] [Abstract][Full Text] [Related]
32. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle. Dokken BB; Sloniger JA; Henriksen EJ Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078 [TBL] [Abstract][Full Text] [Related]
34. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Shiuchi T; Iwai M; Li HS; Wu L; Min LJ; Li JM; Okumura M; Cui TX; Horiuchi M Hypertension; 2004 May; 43(5):1003-10. PubMed ID: 15037562 [TBL] [Abstract][Full Text] [Related]
35. Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Barbour LA; Shao J; Qiao L; Leitner W; Anderson M; Friedman JE; Draznin B Endocrinology; 2004 Mar; 145(3):1144-50. PubMed ID: 14633976 [TBL] [Abstract][Full Text] [Related]
36. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Moon B; Kwan JJ; Duddy N; Sweeney G; Begum N Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E106-15. PubMed ID: 12618360 [TBL] [Abstract][Full Text] [Related]
37. Voluntary running improves glucose tolerance and insulin resistance in female spontaneously hypertensive rats. LaPier TL; Swislocki AL; Clark RJ; Rodnick KJ Am J Hypertens; 2001 Jul; 14(7 Pt 1):708-15. PubMed ID: 11465658 [TBL] [Abstract][Full Text] [Related]
38. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells. Sweeney G; Keen J; Somwar R; Konrad D; Garg R; Klip A Endocrinology; 2001 Nov; 142(11):4806-12. PubMed ID: 11606447 [TBL] [Abstract][Full Text] [Related]
39. Insulin-stimulated cardiac glucose uptake is impaired in spontaneously hypertensive rats: role of early steps of insulin signalling. Morisco C; Condorelli G; Orzi F; Vigliotta G; Di Grezia R; Beguinot F; Trimarco B; Lembo G J Hypertens; 2000 Apr; 18(4):465-73. PubMed ID: 10779099 [TBL] [Abstract][Full Text] [Related]